Trial diversity-it’s time to quit talking and start doing
In order to improve diversity in trials inequities due to economic factors and race need to be bridged at institutional…
By
Global
Latest in
Global
Asia-Pacific has seen the largest growth in oncology-related trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
By
Trikafta/Kaftrio continues to be a game-changer for cystic fibrosis patients
Vertex Pharmaceuticals’ Trikafta/Kaftrio is currently the world’s first triple-combination cystic fibrosis therapy.
By
Macro view: Omicron outbreak forces lockdown in New South Wales
Some economists state that the Omicron outbreak has sparked a de facto lockdown in New South Wales, forcing businesses to…
Pharma developments in 2022: what you need to know
A look at healthcare trends that will likely impact pharma's efforts to research and develop therapeutics in 2022
By
The challenges of multiple drugs safety reporting
Pharmacovigilance of a single drug is one thing, but investigating an adverse event in case of polypharmacy is even more…
By
Filings buzz in pharma: 64% increase in internet of things mentions in Q2 of 2021
Internet of things mentions have increased 280% in the filings of companies in the pharmaceutical industry since 2016
By
Asia-Pacific is seeing a hiring boom in pharmaceutical industry cloud roles
The number of roles in Asia-Pacific made up 17.3%t of the total cloud jobs in the pharmaceutical industry
By